Literature DB >> 21735059

GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies.

Yevgenij Yanovsky1, Stephan Schubring, Wiebke Fleischer, Günter Gisselmann, Xin-Ran Zhu, Hermann Lübbert, Hanns Hatt, Uwe Rudolph, Helmut L Haas, Olga A Sergeeva.   

Abstract

The histaminergic neurons of the posterior hypothalamus (tuberomamillary nucleus-TMN) control wakefulness, and their silencing through activation of GABA(A) receptors (GABA(A)R) induces sleep and is thought to mediate sedation under propofol anaesthesia. We have previously shown that the β1 subunit preferring fragrant dioxane derivatives (FDD) are highly potent modulators of GABA(A)R in TMN neurons. In recombinant receptors containing the β3N265M subunit, FDD action is abolished and GABA potency is reduced. Using rat, wild-type and β3N265M mice, FDD and propofol, we explored the relative contributions of β1- and β3-containing GABA(A)R to synaptic transmission from the GABAergic sleep-on ventrolateral preoptic area neurons to TMN. In β3N265M mice, GABA potency remained unchanged in TMN neurons, but it was decreased in cultured posterior hypothalamic neurons with impaired modulation of GABA(A)R by propofol. Spontaneous and evoked GABAergic synaptic currents (IPSC) showed β1-type pharmacology, with the same effects achieved by 3 μM propofol and 10 μM PI24513. Propofol and the FDD PI24513 suppressed neuronal firing in the majority of neurons at 5 and 100 μM, and in all cells at 10 and 250 μM, respectively. FDD given systemically in mice induced sedation but not anaesthesia. Propofol-induced currents were abolished (1-6 μM) or significantly reduced (12 μM) in β3N265M mice, whereas gating and modulation of GABA(A)R by PI24513 as well as modulation by propofol were unchanged. In conclusion, β1-containing (FDD-sensitive) GABA(A)R represent the major receptor pool in TMN neurons responding to GABA, while β3-containing (FDD-insensitive) receptors are gated by low micromolar doses of propofol. Thus, sleep and anaesthesia depend on different GABA(A)R types.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735059     DOI: 10.1007/s00424-011-0988-4

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  42 in total

1.  GABA(A) receptor heterogeneity in histaminergic neurons.

Authors:  Olga A Sergeeva; Krister S Eriksson; Irina N Sharonova; Vladimir S Vorobjev; Helmut L Haas
Journal:  Eur J Neurosci       Date:  2002-10       Impact factor: 3.386

Review 2.  Sleep-promoting functions of the hypothalamic median preoptic nucleus: inhibition of arousal systems.

Authors:  D McGinty; H Gong; N Suntsova; Md N Alam; M Methippara; R Guzman-Marin; R Szymusiak
Journal:  Arch Ital Biol       Date:  2004-07       Impact factor: 1.000

3.  Identification of sleep-promoting neurons in vitro.

Authors:  T Gallopin; P Fort; E Eggermann; B Cauli; P H Luppi; J Rossier; E Audinat; M Mühlethaler; M Serafin
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

4.  Suppression of central nervous system sodium channels by propofol.

Authors:  B Rehberg; D S Duch
Journal:  Anesthesiology       Date:  1999-08       Impact factor: 7.892

5.  Alpha5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate.

Authors:  Victor Y Cheng; Loren J Martin; Erin M Elliott; John H Kim; Howard T J Mount; Franco A Taverna; John C Roder; John F Macdonald; Amit Bhambri; Neil Collinson; Keith A Wafford; Beverley A Orser
Journal:  J Neurosci       Date:  2006-04-05       Impact factor: 6.167

6.  Hydroxyamide analogs of propofol exhibit state-dependent block of sodium channels in hippocampal neurons: implications for anticonvulsant activity.

Authors:  Paulianda J Jones; Yuesheng Wang; Misty D Smith; Nicholas J Hargus; Hilary S Eidam; H Steve White; Jaideep Kapur; Milton L Brown; Manoj K Patel
Journal:  J Pharmacol Exp Ther       Date:  2006-11-07       Impact factor: 4.030

7.  Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat.

Authors:  T L Steininger; M N Alam; H Gong; R Szymusiak; D McGinty
Journal:  Brain Res       Date:  1999-09-04       Impact factor: 3.252

Review 8.  GABA(A) receptor subtypes underlying general anesthesia.

Authors:  Robert P Bonin; Beverley A Orser
Journal:  Pharmacol Biochem Behav       Date:  2008-01-16       Impact factor: 3.533

9.  Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms.

Authors:  David S Reynolds; Thomas W Rosahl; Jennifer Cirone; Gillian F O'Meara; Alison Haythornthwaite; Richard J Newman; Janice Myers; Cyrille Sur; Owain Howell; A Richard Rutter; John Atack; Alison J Macaulay; Karen L Hadingham; Peter H Hutson; Delia Belelli; Jeremy J Lambert; Gerard R Dawson; Ruth McKernan; Paul J Whiting; Keith A Wafford
Journal:  J Neurosci       Date:  2003-09-17       Impact factor: 6.167

10.  Behavior and cellular evidence for propofol-induced hypnosis involving brain glycine receptors.

Authors:  Hai T Nguyen; Ke-yong Li; Ralph L daGraca; Ellise Delphin; Ming Xiong; Jiang H Ye
Journal:  Anesthesiology       Date:  2009-02       Impact factor: 7.892

View more
  16 in total

Review 1.  A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface.

Authors:  Werner Sieghart; Joachim Ramerstorfer; Isabella Sarto-Jackson; Zdravko Varagic; Margot Ernst
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Histaminergic H1 and H2 Receptors Mediate the Effects of Propofol on the Noradrenalin-Inhibited Neurons in Rat Ventrolateral Preoptic Nucleus.

Authors:  Yang Liu; Yu Zhang; Kun Qian; Lin Zhang; Tian Yu
Journal:  Neurochem Res       Date:  2017-02-09       Impact factor: 3.996

3.  Inactivation of the Tuberomammillary Nucleus by GABAA Receptor Agonist Promotes Slow Wave Sleep in Freely Moving Rats and Histamine-Treated Rats.

Authors:  Jun-Fan Xie; Kun Fan; Can Wang; Peng Xie; Min Hou; Le Xin; Guang-Fu Cui; Lin-Xin Wang; Yu-Feng Shao; Yi-Ping Hou
Journal:  Neurochem Res       Date:  2017-04-01       Impact factor: 3.996

4.  Benzodiazepine-site pharmacology on GABAA receptors in histaminergic neurons.

Authors:  A C May; W Fleischer; O Kletke; H L Haas; O A Sergeeva
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

5.  α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB).

Authors:  Nathan Absalom; Laura F Eghorn; Inge S Villumsen; Nasiara Karim; Tina Bay; Jesper V Olsen; Gitte M Knudsen; Hans Bräuner-Osborne; Bente Frølund; Rasmus P Clausen; Mary Chebib; Petrine Wellendorph
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

6.  Proton- and ammonium-sensing by histaminergic neurons controlling wakefulness.

Authors:  Yevgenij Yanovsky; Jeffrey M Zigman; Anna Kernder; Alisa Bein; Ichiro Sakata; Sherri Osborne-Lawrence; Helmut L Haas; Olga A Sergeeva
Journal:  Front Syst Neurosci       Date:  2012-04-13

7.  Pharmacological characterisation of murine α4β1δ GABAA receptors expressed in Xenopus oocytes.

Authors:  Inge S Villumsen; Petrine Wellendorph; Trevor G Smart
Journal:  BMC Neurosci       Date:  2015-03-05       Impact factor: 3.288

8.  GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness.

Authors:  Anna Y Zecharia; Xiao Yu; Thomas Götz; Zhiwen Ye; David R Carr; Peer Wulff; Bernhard Bettler; Alexei L Vyssotski; Stephen G Brickley; Nicholas P Franks; William Wisden
Journal:  J Neurosci       Date:  2012-09-19       Impact factor: 6.167

9.  Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block.

Authors:  Yevgenij Yanovsky; Stephan R Schubring; Quiaoling Yao; Yan Zhao; Sha Li; Andrea May; Helmut L Haas; Jian-Sheng Lin; Olga A Sergeeva
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

10.  Partial agonism of taurine at gamma-containing native and recombinant GABAA receptors.

Authors:  Olaf Kletke; Guenter Gisselmann; Andrea May; Hanns Hatt; Olga A Sergeeva
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.